ATE522219T1 - Zusammensetzungen zur hemmung oder behandlung von hepatitis-c-viren - Google Patents

Zusammensetzungen zur hemmung oder behandlung von hepatitis-c-viren

Info

Publication number
ATE522219T1
ATE522219T1 AT10153974T AT10153974T ATE522219T1 AT E522219 T1 ATE522219 T1 AT E522219T1 AT 10153974 T AT10153974 T AT 10153974T AT 10153974 T AT10153974 T AT 10153974T AT E522219 T1 ATE522219 T1 AT E522219T1
Authority
AT
Austria
Prior art keywords
hepatitis
inhibiting
viruses
compositions
treating hepatitis
Prior art date
Application number
AT10153974T
Other languages
English (en)
Inventor
Lain-Tze Lee
Shau-Feng Chang
Hui-Ping Tsai
Zong-Keng Kuo
Chen-Fang Chung
Original Assignee
Ind Tech Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Tech Res Inst filed Critical Ind Tech Res Inst
Application granted granted Critical
Publication of ATE522219T1 publication Critical patent/ATE522219T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
AT10153974T 2009-06-16 2010-02-18 Zusammensetzungen zur hemmung oder behandlung von hepatitis-c-viren ATE522219T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW98120040 2009-06-16
TW098136423A TWI351280B (en) 2009-06-16 2009-10-28 Anti-hepatitis c composition, method for preparing

Publications (1)

Publication Number Publication Date
ATE522219T1 true ATE522219T1 (de) 2011-09-15

Family

ID=42712431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT10153974T ATE522219T1 (de) 2009-06-16 2010-02-18 Zusammensetzungen zur hemmung oder behandlung von hepatitis-c-viren

Country Status (4)

Country Link
EP (1) EP2263676B1 (de)
JP (1) JP5172894B2 (de)
AT (1) ATE522219T1 (de)
TW (1) TWI351280B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4177C1 (ro) * 2011-01-14 2013-02-28 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Metodă de vaccinare contra hepatitei virale B a persoanelor imunocompromise
JP2012167023A (ja) * 2011-02-09 2012-09-06 Kao Corp セラミド産生促進剤、保湿剤及び皮膚外用剤
JP2012167063A (ja) * 2011-02-15 2012-09-06 Kao Corp ドーパオキシダーゼ活性抑制剤及び美白剤
CN103907627B (zh) * 2013-01-09 2015-07-01 中国科学院海洋研究所 一种四环三萜类化合物作为制备低剂量轮虫杀虫剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1476829A (zh) * 2003-07-16 2004-02-25 中国科学院上海生命科学研究院 川楝素作为抗肿瘤药物的应用
CN100333756C (zh) * 2004-05-25 2007-08-29 李春光 治疗肝炎的中药制剂及其制备方法
CN101181567B (zh) * 2007-11-28 2010-06-16 王科先 一种治疗慢性乙型肝炎肝纤维化的药物

Also Published As

Publication number Publication date
EP2263676A1 (de) 2010-12-22
TWI351280B (en) 2011-11-01
TW201100077A (en) 2011-01-01
JP5172894B2 (ja) 2013-03-27
JP2011001345A (ja) 2011-01-06
EP2263676B1 (de) 2011-08-31

Similar Documents

Publication Publication Date Title
EA201071034A1 (ru) Новые макроциклические ингибиторы репликаций вируса гепатита с
EA201100390A1 (ru) Соединения для лечения гепатита с
ATE522532T1 (de) Verbindungen zur behandlung von hepatitis c
ATE551343T1 (de) Tetracyclische verbindungen zur behandlung von hepatitis c
EA201001273A1 (ru) Ингибиторы вируса гепатита с
ZA201002690B (en) N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors
WO2010030538A3 (en) Compounds for the treatment of hepatitis c
EA201101240A1 (ru) Ингибиторы вируса гепатита с
MX2012004032A (es) Compuestos para el tratamiento de hepatitis c.
EA201370078A1 (ru) Ингибиторы вируса гепатита с
EA201171152A1 (ru) Ингибиторы вируса гепатита c
MX2009009473A (es) Compuestos para el tratamiento de hepatitis c.
EA201390538A1 (ru) Противовирусные соединения
EA201001275A1 (ru) Конформационно-ограниченные бифенильные производные для применения в качестве ингибиторов вируса гепатита с
NZ595186A (en) Di-pyrazolidinyl-biphenylyl compounds for treating hepatitis C virus (HCV) infection
ECSP088518A (es) Nucleósidos antivirales
MX2012008443A (es) Nucleosidos antiviricos.
DOP2010000052A (es) Entidades quimicas biciclicas que contienen nitrogeno para el tratamiento de infecciones virales
PH12013500770A1 (en) Inhibitors of hepatitis c virus
MX2009008439A (es) Nuevos inhibidores de la replicacion del virus de hepatitis c.
EA200900676A1 (ru) Ингибиторы вируса гепатита с
EA201270656A1 (ru) Ингибиторы вируса гепатита с
WO2007103550A3 (en) Substituted aminothiazole derivatives with anti-hcv activity
DK2250163T3 (da) Hepatitis C-virusinhibitorer
ATE505473T1 (de) Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties